These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 33242829)
1. Tools for the targeted genetic modification of poxvirus genomes. Matía A; Lorenzo MM; Blasco R Curr Opin Virol; 2020 Oct; 44():183-190. PubMed ID: 33242829 [TBL] [Abstract][Full Text] [Related]
2. Vaccinia and other poxvirus expression vectors. Moss B Curr Opin Biotechnol; 1992 Oct; 3(5):518-22. PubMed ID: 1368937 [TBL] [Abstract][Full Text] [Related]
3. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines. Tang N; Zhang Y; Shen Z; Yao Y; Nair V CRISPR J; 2021 Aug; 4(4):477-490. PubMed ID: 34406035 [TBL] [Abstract][Full Text] [Related]
6. Poxvirus cancer therapy. Gilbert PA; McFadden G Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):309-21. PubMed ID: 18221156 [TBL] [Abstract][Full Text] [Related]
7. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines. Taylor J; Paoletti E Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866 [TBL] [Abstract][Full Text] [Related]
12. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. Hwang C; Sanda MG Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762 [TBL] [Abstract][Full Text] [Related]
13. A selectable and excisable marker system for the rapid creation of recombinant poxviruses. Rintoul JL; Wang J; Gammon DB; van Buuren NJ; Garson K; Jardine K; Barry M; Evans DH; Bell JC PLoS One; 2011; 6(9):e24643. PubMed ID: 21931792 [TBL] [Abstract][Full Text] [Related]